Your session is about to expire
← Back to Search
Remote Mental Health Training for Mental Illness
N/A
Waitlist Available
Led By Ricardo B Eiraldi, PhD
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group
Summary
This trialsuggests remote video tech is needed to train rural school staff on mental health practices.
Who is the study for?
This trial is for counselors, social workers, or teachers from schools using PBIS with students in grades 4-8. Principals and assistant principals can also participate. Students eligible are those attending these schools who need extra support after Tier 1 intervention and score high on the SDQ for emotional or conduct issues.
What is being tested?
The study tests a remote training strategy to help school staff implement mental health practices effectively. It compares initial training alone (CC), with added video (RV), and both plus coaching (RV+). Interventions include CPP, CATS, and CI/CO within a PBIS framework.
What are the potential side effects?
Since this trial involves educational strategies rather than medical treatments, traditional side effects are not applicable. However, there may be indirect impacts on student behavior or stress levels among staff due to new implementation processes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in academic engagement from Baseline to Post Intervention
Changes in externalizing and internalizing problems
Changes in student mental health symptoms from Baseline to Post Intervention
+4 moreSecondary study objectives
Perceived mediators and moderators of consultation support
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Initial training plus video, plus coachingExperimental Treatment4 Interventions
School personnel will implement CATS or CPP and CICO with students in the school setting. They will participate in an initial live remote training, receive access to asynchronous video training modules about the EBPs, and receive coaching support by study staff (RV+). The coaching will be from a study consultant regarding the implementation of EBPs.
Group II: Initial training plus videoExperimental Treatment4 Interventions
School personnel will implement CATS or CPP and CICO with students in the school setting. They will participate in an initial live remote training and receive access to asynchronous video training modules about the EBPs (RV).
Group III: Initial trainingActive Control4 Interventions
School personnel will implement CATS or CPP and CICO with students in the school setting. They will participate in an initial live remote training to learn about implementing the three EBPs (CC).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Coping Power Program (CPP)
2020
N/A
~30
Check-in/Check-out (CI/CO)
2020
N/A
~30
Find a Location
Who is running the clinical trial?
Children's Hospital of PhiladelphiaLead Sponsor
729 Previous Clinical Trials
8,469,864 Total Patients Enrolled
Devereux Center for Effective SchoolsUNKNOWN
2 Previous Clinical Trials
520 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
406 Previous Clinical Trials
6,756,790 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a student in grades 4-8, not helped by initial school support, and scored high on a behavior or emotional test.
Research Study Groups:
This trial has the following groups:- Group 1: Initial training
- Group 2: Initial training plus video
- Group 3: Initial training plus video, plus coaching
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger